mesalamine has been researched along with Hypercoagulability in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leal-Valdivieso, C | 1 |
| Naves, JE | 1 |
| Mañosa, M | 1 |
| Zabana, Y | 1 |
| Cabré, E | 1 |
| Domènech, E | 1 |
| Vrij, AA | 1 |
| Oberndorff-Klein-Woolthuis, A | 1 |
| Dijkstra, G | 1 |
| de Jong, AE | 1 |
| Wagenvoord, R | 1 |
| Hemker, HC | 1 |
| Stockbrügger, RW | 1 |
1 trial available for mesalamine and Hypercoagulability
| Article | Year |
|---|---|
Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin.
Topics: Adult; Colitis, Ulcerative; Double-Blind Method; Female; Hemostasis; Heparin, Low-Molecular-Weight; | 2007 |
1 other study available for mesalamine and Hypercoagulability
| Article | Year |
|---|---|
[Portal hypertension in patients with inflammatory bowel disease].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Ascites; Crohn Disease; Female; | 2010 |